256 related articles for article (PubMed ID: 17133606)
1. Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.
Margheri F; Manetti M; Serratì S; Nosi D; Pucci M; Matucci-Cerinic M; Kahaleh B; Bazzichi L; Fibbi G; Ibba-Manneschi L; Del Rosso M
Arthritis Rheum; 2006 Dec; 54(12):3926-38. PubMed ID: 17133606
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
D'Alessio S; Fibbi G; Cinelli M; Guiducci S; Del Rosso A; Margheri F; Serratì S; Pucci M; Kahaleh B; Fan P; Annunziato F; Cosmi L; Liotta F; Matucci-Cerinic M; Del Rosso M
Arthritis Rheum; 2004 Oct; 50(10):3275-85. PubMed ID: 15476218
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
Margheri F; Serratì S; Lapucci A; Chillà A; Bazzichi L; Bombardieri S; Kahaleh B; Calorini L; Bianchini F; Fibbi G; Del Rosso M
Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis.
Giusti B; Margheri F; Rossi L; Lapini I; Magi A; Serratì S; Chillà A; Laurenzana A; Magnelli L; Calorini L; Bianchini F; Fibbi G; Abbate R; Del Rosso M
PLoS One; 2013; 8(7):e68117. PubMed ID: 23874518
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
[TBL] [Abstract][Full Text] [Related]
6. Urokinase anchors uPAR to the actin cytoskeleton.
Bernstein AM; Greenberg RS; Taliana L; Masur SK
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2967-77. PubMed ID: 15326109
[TBL] [Abstract][Full Text] [Related]
7. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
Xue W; Mizukami I; Todd RF; Petty HR
Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
[TBL] [Abstract][Full Text] [Related]
9. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin.
Kjøller L; Hall A
J Cell Biol; 2001 Mar; 152(6):1145-57. PubMed ID: 11257116
[TBL] [Abstract][Full Text] [Related]
10. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
[TBL] [Abstract][Full Text] [Related]
11. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
[TBL] [Abstract][Full Text] [Related]
13. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function.
Simon DI; Wei Y; Zhang L; Rao NK; Xu H; Chen Z; Liu Q; Rosenberg S; Chapman HA
J Biol Chem; 2000 Apr; 275(14):10228-34. PubMed ID: 10744708
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
Ahmed N; Oliva K; Wang Y; Quinn M; Rice G
Br J Cancer; 2003 Jul; 89(2):374-84. PubMed ID: 12865932
[TBL] [Abstract][Full Text] [Related]
15. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
May AE; Kanse SM; Lund LR; Gisler RH; Imhof BA; Preissner KT
J Exp Med; 1998 Sep; 188(6):1029-37. PubMed ID: 9743521
[TBL] [Abstract][Full Text] [Related]
16. A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.
Hillig T; Engelholm LH; Ingvarsen S; Madsen DH; Gårdsvoll H; Larsen JK; Ploug M; Danø K; Kjøller L; Behrendt N
J Biol Chem; 2008 May; 283(22):15217-23. PubMed ID: 18362146
[TBL] [Abstract][Full Text] [Related]
17. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
18. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
[TBL] [Abstract][Full Text] [Related]
19. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]